Novo Nordisk Canada Partners with Rexall for Ozempic, Wegovy Home Delivery
Event summary
- Novo Nordisk Canada and Rexall Pharmacy launched Novo Nordisk Care® Rx on May 13, 2026, offering home delivery for Ozempic®, Wegovy®, and Rybelsus®.
- The service provides no-cost home delivery and personalized pharmacist support through Rexall Direct.
- Available across all Canadian provinces except Quebec, the partnership aims to reduce in-person pharmacy visits and support chronic condition management.
- Novo Nordisk Care® Rx automatically applies savings for eligible patients with no subscription fee.
The big picture
This partnership aligns with the broader trend of pharmaceutical companies collaborating with retail pharmacies to enhance patient access and adherence. Novo Nordisk’s move reflects a strategic shift toward digital health solutions, particularly for chronic conditions like diabetes and obesity. The collaboration also addresses systemic barriers, such as weight bias and stigma, that hinder healthcare access for obesity patients.
What we're watching
- Market Expansion
- Whether Novo Nordisk can sustain growth in home delivery demand for GLP-1 medications across Canada.
- Regulatory Compliance
- The pace at which similar partnerships emerge in response to healthcare accessibility mandates.
- Operational Efficiency
- How the integration of Novo Nordisk’s supply chain with Rexall’s logistics impacts delivery times and costs.
Related topics